Virtual Screening and Molecular Docking of FDA Approved Antiviral Drugs for the Identification of Potential Inhibitors of SARS-CoV-2 RNA-MTase Protein
1. Virtual Screening and Molecular Docking of FDA Approved Antiviral Drugs for the Identification of Potential Inhibitors of SARS-CoV-2 RNA-MTase Protein

Samavia Jaan; Sara Waheed; Sidra Bashir; Muhammad Sameem Javed; Adnan Amjad; Umar Nishan; Haq Nawaz; Mohibullah Shah

Volume 9, Issue 1 , Winter 2021, , Pages 105-118

http://dx.doi.org/10.22034/ijabbr.2021.46320

Abstract
  Background: SARS-CoV-2 is a novel coronavirus discovered in December 2019 and is responsible for pandemic disease COVID-19. In the absence of any available vaccines or drugs to combat ...  Read More